in dengue infection (Bhaskar, 2015).
In our case, the
patient has massive gastrointestinal bleeding. A
study showed ascites could be found in 34% dengue
infection patients with gastrointestinal bleeding
(Huang, 2018). This was similar to our finding, our
severe dengue patient developed ascites and proved
by ultrasound result. In another study showed
increase level of AST more than 200 in severe
dengue while other only 80 (Pone, 2016; Bhaskar,
2015). In our case, the AST level increase slightly
above 100.
More than 78% children with spontaneous
bleeding had decrease platelet count and 75%
bleeding manifestation occurred in patients with
platelet <20,000/mm
3
as reported in a study
(Chairulfatah, 2003). This was confirmed in our
case, where the platelet level was 16,000/mm
3
on
admission and patient had gastrointestinal bleeding.
Platelet transfusion could be given in dengue
infection with active bleeding and platelet count
<50,000/mm
3
(Photapregadha, 2015). In our case,
we gave transfusion with whole blood because
hemoglobin level also decreased due to active
bleeding. The mechanism of bleeding manifestation
in dengue infection is multifactorial, including
coagulation defects (Photapregadha, 2015).
This was
proved in our case which APTT level also disturbed.
Among all dengue infection, about 4.3% cases will
develop to expanded dengue syndrome with
different manifestations (Laul, 2016).
Our report
found fluid overload and urinary tract infection as
co-infection as manifestation of expanded dengue
syndrome.
4 CONCLUSION
We have treated a 7 year old girl who came with
history of fever for 4 days, bilateral pleural effusion,
ascites, massive gastrointestinal bleeding, severe
thrombocytopenia, and co-infection with urinary
tract infection. She was diagnosed with severe
dengue infection with expanded dengue syndrome.
The patient was hospitalized for 5 days and was
discharged with great improvement.
REFERENCES
WHO, “Comprehensive guidelines for prevention and
control of dengue and dengue hemorrhagic fever”,
World Health Organization, Regional Office for
South-East Asia,
http://apps.searo.who.int/pds_docs/B4751.pdf?ua=1
Bhatt S., Gething P.W., Brady O.J., et al. The global
distribution and burden of dengue.
Nature.2013;496:504-7.
Dengue hemorrhagic fever: Diagnosis, treatment,
prevention and control. II ed. Geneva: World Health
Organization 2011.
Gulati S., Maheshwari A., 2007. “ Atypical manifestations
of dengue,” Tropical Medicine and International
Health, vol 12,no.9,pp.1087-1095.
Mandal S.K., Ganguly J., Sil K., et al., 2013. Clinical
profiles of dengue fever in a teaching hospital of
eastern Indian, ”National Journal of Medical
Research,vol.3, no.2,pp.173-176.
Mishra S., Ramanathan R., Agarwalla S., 2016. Scientica.
http://dx.doi.org/10.1155/2016/6391594
Laul A., Laul P., Merugumala V., et al. Clinical profile of
dengue infection during outbreak in Northern India. J
Trop Med 2016.
http://dx.doi.org/10.1155/2016/5917934
Pone S., Hokerberg Y., Oliveira R., et al. Clinical and
laboratory signs associated to serious dengue disease
in hospitalized children. J Pediatr (Rio J)
2016;92(5):464-471
Bhaskar E., Sowmya G., Moorthy S., Sundar V.,
Prevalence, patterns, and factors associated with
bleeding tendencies in dengue. J Infect Dev Ctries
2015;9(1):105-110.
Huang W., Lee I., Chen Y., Tsai C., Liu J., Characteristics
and predictors for gastrointestinal hemorrhage among
adult patients with dengue virus infection:
emphasizing the impact of existing comorbid
disease(s). PLos One 2018;13(2):e0192919
Chairulfatah A., Setiabudi D., Agoes R., Colebunders R.,
Trombocytopenia and platelet transfusion in dengue
hemorrhagic fever and dengue shock syndrome. WHO
Dengue Bull 2003;27:141-3
Pothapregada S., Kamalakannan B., Thulasingam M.,
Role of platelet transfusion in children with bleeding
in dengue fever. J vector Borne Dis 2015;52:304-8